FR2966365B1 - Composition de gel topique - Google Patents

Composition de gel topique

Info

Publication number
FR2966365B1
FR2966365B1 FR1058611A FR1058611A FR2966365B1 FR 2966365 B1 FR2966365 B1 FR 2966365B1 FR 1058611 A FR1058611 A FR 1058611A FR 1058611 A FR1058611 A FR 1058611A FR 2966365 B1 FR2966365 B1 FR 2966365B1
Authority
FR
France
Prior art keywords
gel composition
topical gel
topical
composition
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1058611A
Other languages
English (en)
Other versions
FR2966365A1 (fr
Inventor
Jean Christophe Buge
Fourcade Karine Nadau
Cyril Meunier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1058611A priority Critical patent/FR2966365B1/fr
Application filed by Galderma SA filed Critical Galderma SA
Priority to PCT/EP2011/068261 priority patent/WO2012052478A2/fr
Priority to SG2013026679A priority patent/SG189338A1/en
Priority to JP2013534308A priority patent/JP2013540142A/ja
Priority to EP11771146.5A priority patent/EP2605753A2/fr
Priority to KR1020137012906A priority patent/KR20130101552A/ko
Priority to RU2013123043/15A priority patent/RU2013123043A/ru
Priority to MX2013004472A priority patent/MX2013004472A/es
Priority to CA2814975A priority patent/CA2814975A1/fr
Priority to AU2011317642A priority patent/AU2011317642A1/en
Priority to CN2011800509124A priority patent/CN103313700A/zh
Priority to BR112013009577A priority patent/BR112013009577A2/pt
Publication of FR2966365A1 publication Critical patent/FR2966365A1/fr
Application granted granted Critical
Publication of FR2966365B1 publication Critical patent/FR2966365B1/fr
Priority to IL225775A priority patent/IL225775A0/en
Priority to ZA2013/02812A priority patent/ZA201302812B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
FR1058611A 2010-10-21 2010-10-21 Composition de gel topique Expired - Fee Related FR2966365B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR1058611A FR2966365B1 (fr) 2010-10-21 2010-10-21 Composition de gel topique
CN2011800509124A CN103313700A (zh) 2010-10-21 2011-10-19 外用凝胶剂组合物
JP2013534308A JP2013540142A (ja) 2010-10-21 2011-10-19 局所ゲル組成物
EP11771146.5A EP2605753A2 (fr) 2010-10-21 2011-10-19 Composition de gel topique
KR1020137012906A KR20130101552A (ko) 2010-10-21 2011-10-19 국소용 겔 조성물
RU2013123043/15A RU2013123043A (ru) 2010-10-21 2011-10-19 Гелевая композиция для местного применения
MX2013004472A MX2013004472A (es) 2010-10-21 2011-10-19 Composicion topica de gel.
CA2814975A CA2814975A1 (fr) 2010-10-21 2011-10-19 Composition de gel topique
PCT/EP2011/068261 WO2012052478A2 (fr) 2010-10-21 2011-10-19 Composition de gel topique
SG2013026679A SG189338A1 (en) 2010-10-21 2011-10-19 Topical gel composition
BR112013009577A BR112013009577A2 (pt) 2010-10-21 2011-10-19 composição de gel tópico e método
AU2011317642A AU2011317642A1 (en) 2010-10-21 2011-10-19 Topical gel composition
IL225775A IL225775A0 (en) 2010-10-21 2013-04-15 Gel compound for local use
ZA2013/02812A ZA201302812B (en) 2010-10-21 2013-04-18 Topical gel composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1058611A FR2966365B1 (fr) 2010-10-21 2010-10-21 Composition de gel topique

Publications (2)

Publication Number Publication Date
FR2966365A1 FR2966365A1 (fr) 2012-04-27
FR2966365B1 true FR2966365B1 (fr) 2012-11-09

Family

ID=43734187

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1058611A Expired - Fee Related FR2966365B1 (fr) 2010-10-21 2010-10-21 Composition de gel topique

Country Status (1)

Country Link
FR (1) FR2966365B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015148910A (ru) * 2013-05-06 2017-06-13 Аллерган, Инк. Альфа-адренергические агонисты для лечения повреждения тканей

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US20090061020A1 (en) * 2007-08-31 2009-03-05 Theobald Klaus P Brimonidine Compositions for Treating Erythema
JP5580210B2 (ja) * 2007-12-21 2014-08-27 ガルデマ ラボラトリーズ インコーポレイテッド 手術前治療

Also Published As

Publication number Publication date
FR2966365A1 (fr) 2012-04-27

Similar Documents

Publication Publication Date Title
SMT201700008B (it) Composizione farmaceutica
BR112013011472A2 (pt) Composição de gel
BR112013016037A2 (pt) composição em gel.
BR112012031667A2 (pt) composição
BRPI1009281A2 (pt) composição oftálmica tópica
DK2526158T3 (da) Forbedret klæbemiddelsammensætning
DK3257890T3 (da) Tværbindelig sammensætning
BR112012032683A2 (pt) composição
DK3246018T3 (da) Farmaceutisk sammensætning
BR112013013445A2 (pt) composição tópica promotora de melanina
EE201300005A (et) Ravimkoostis
BR112012027261A2 (pt) composição de shampoo condicionador
BR112012032980A2 (pt) composição
FR2955770B1 (fr) Composition cosmetique.
DK2444068T3 (da) Brimonidingelpræparat
BR112012013182A2 (pt) composições tópicas germicidas
ZA201302812B (en) Topical gel composition
FR2957252B1 (fr) Composition cosmetique
EP2555784A4 (fr) Composition de gel à base de miel
BR112012015386A2 (pt) composição oftálmica tópica
FR2957787B1 (fr) Composition de maquillage
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina
BR112013014821A2 (pt) géis espalháveis
FR2961401B1 (fr) Composition anti-inflammatoire
BRPI1007164A2 (pt) composição tópica

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160630